Pancreatic Cancer Research

ResearcherUniversity of UtahNo recent work listed

Douglas S. Swords

Matched on ORCID iD 0000-0002-5002-6992; OpenAlex author ID A5045980487. Sources: OpenAlex.

Their work

Papers
10
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2015: 1 paper · 2016: 1 paper · 2017: 1 paper · 2018: 2 papers · 2019: 3 papers · 2020: 1 paper · 2021: 1 paper

Papers 10

  1. Decompositions of the Contribution of Treatment Disparities to Survival Disparities in Stage I-II Pancreatic Adenocarcinoma. Co-author DOI 10.1245/s10434-020-09267-y↗
  2. County-level Variation in Use of Surgery and Cancer-specific Survival for Stage I-II Pancreatic Adenocarcinoma. Co-author DOI 10.1097/sla.0000000000003236↗
  3. Lymph Node Ratio in Pancreatic Adenocarcinoma After Preoperative Chemotherapy vs. Preoperative Chemoradiation and Its Utility in Decisions About Postoperative … Co-author DOI 10.1007/s11605-018-3953-0↗
  4. Disparities in utilization of treatment for clinical stage I-II pancreatic adenocarcinoma by area socioeconomic status and race/ethnicity. Co-author DOI 10.1016/j.surg.2018.10.035↗
  5. Hospital-level Variation in Utilization of Surgery for Clinical Stage I-II Pancreatic Adenocarcinoma. Co-author DOI 10.1097/sla.0000000000002404↗
  6. Causes of Death and Conditional Survival Estimates of Medium- and Long-term Survivors of Pancreatic Adenocarcinoma. Co-author DOI 10.1001/jamaoncol.2018.2442↗
  7. Association of time-to-surgery with outcomes in clinical stage I-II pancreatic adenocarcinoma treated with upfront surgery. Co-author DOI 10.1016/j.surg.2017.10.054↗
  8. Implications of inaccurate clinical nodal staging in pancreatic adenocarcinoma. Co-author DOI 10.1016/j.surg.2016.12.029↗
  9. Biomarkers in pancreatic adenocarcinoma: current perspectives. Co-author DOI 10.2147/ott.s100510↗
  10. Initial Misdiagnosis of Proximal Pancreatic Adenocarcinoma Is Associated with Delay in Diagnosis and Advanced Stage at Presentation. Co-author DOI 10.1007/s11605-015-2923-z↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Courtney L. Scaife · 10 shared papers, 2015–2021 · strength 1.16
  2. Sean J. Mulvihill · 9 shared papers, 2015–2020 · strength 0.88
  3. Matthew A. Firpo · 8 shared papers, 2016–2020 · strength 0.82
  4. Shane A. J. Lloyd · 1 shared paper, 2019 · strength 0.09
  5. Joshua David Gruhl · 1 shared paper, 2019 · strength 0.09
  6. Ignacio Garrido‐Laguna · 1 shared paper, 2019 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.